The potential protective role of corticosteroid therapy in patients with asthma and COPD against COVID-19
Abstract Background The observation of patients hospitalized for coronavirus disease (COVID-19) led us to note a lower prevalence of patients affected by chronic respiratory disease, in particular asthmatic patients, compared to the general population. Therefore, the aim of this paper is to evaluate...
Enregistré dans:
Auteurs principaux: | Fabiana Furci, Marco Caminati, Gianenrico Senna, Sebastiano Gangemi |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMC
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/9b0b360605594d36b38cf0deb56612de |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Pharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma
par: Priyadarshini Kachroo, et autres
Publié: (2021) -
Small Airways Response to Bronchodilators in Adults with Asthma or COPD: A Systematic Review
par: Almeshari MA, et autres
Publié: (2021) -
COPD: What the anaesthetist should know
par: M. L. Wong
Publié: (2016) -
Effectiveness of Telemonitoring for Respiratory and Systemic Symptoms of Asthma and COPD: A Narrative Review
par: Esther Metting, et autres
Publié: (2021) -
Racial Differences in Prevalence and Clinical Characteristics of Asthma–Chronic Obstructive Pulmonary Disease Overlap
par: Yong Suk Jo, et autres
Publié: (2021)